Pages that link to "Item:Q2029579"
From MaRDI portal
The following pages link to A mechanistic systems pharmacology modeling platform to investigate the effect of PD-L1 expression heterogeneity and dynamics on the efficacy of PD-1 and PD-L1 blocking antibodies in cancer (Q2029579):
Displaying 3 items.
- Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer (Q2164665) (← links)
- Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity (Q2295757) (← links)
- Modeling tumour heterogeneity of PD-L1 expression in tumour progression and adaptive therapy (Q2684038) (← links)
